Suppr超能文献

基于 Ru(II) 菲咯啉的寡聚噻吩配合物作为光疗试剂。

Ru(II) Phenanthroline-Based Oligothienyl Complexes as Phototherapy Agents.

机构信息

Department of Chemistry and Biochemistry, The University of Texas at Arlington, Arlington, Texas 76019-0065, United States.

Department of Chemistry and Biochemistry, The University of North Carolina at Greensboro, Greensboro, North Carolina 27402, United States.

出版信息

Inorg Chem. 2023 Dec 25;62(51):21181-21200. doi: 10.1021/acs.inorgchem.3c03216. Epub 2023 Dec 11.

Abstract

Ru(II) polypyridyl complexes have gained widespread attention as photosensitizers for photodynamic therapy (PDT). Herein, we systematically investigate a series of the type [Ru(phen)(IP-T)], featuring 1,10-phenanthroline (phen) coligands and imidazo[4,5-][1,10]phenanthroline ligands tethered to 0-4 thiophene rings (IP-T). The complexes were characterized and investigated for their electrochemical, spectroscopic, and (photo)biological properties. The electrochemical oxidation of the T unit shifted by -350 mV as = 1 → 4 (+920 mV for , +570 mV for ); T reductions were observed in complexes (-2530 mV) and (-2300 mV). Singlet oxygen quantum yields ranged from 0.53 to 0.88, with and being equally efficient (∼0.88). Time-resolved absorption spectra of - were dominated by metal-to-ligand charge-transfer (MLCT) states (τ = 0.40-0.85 μs), but long-lived intraligand charge-transfer (ILCT) states were observed in - (τ = 25-148 μs). The ILCT energies of and were computed to be 1.6 and 1.4 eV, respectively. The phototherapeutic efficacy against melanoma cells (SK-MEL-28) under broad-band visible light (400-700 nm) increases as = 0 → 4: was inactive up to 300 μM, - were moderately active (EC ∼ 600 nM, PI = 200), and (EC = 57 nM, PI > 1100) and (EC = 740 pM, PI = 114,000) were the most phototoxic. The activity diminishes with longer wavelengths of light and is completely suppressed for all complexes except and in hypoxia. is the more potent and robust PS in 1% O over seven biological replicates (avg EC = 1.3 μM, avg PI = 985). exhibited hypoxic activity in five of seven replicates, underscoring the need for biological replicates in compound evaluation. Singlet oxygen sensitization is likely responsible for phototoxic effects of the compounds in normoxia, but the presence of redox-active excited states may facilitate additional photoactive pathways for complexes with three or more thienyl groups. The ILCT state with its extended lifetime (30-40× longer than the MLCT state for and ) implicates its predominant role in photocytotoxicity.

摘要

钌(II)多吡啶配合物作为光动力疗法(PDT)的光敏剂受到了广泛关注。在这里,我们系统地研究了一系列[Ru(phen)(IP-T)]型配合物,其特征为 1,10-菲咯啉(phen)共配体和连接到 0-4 噻吩环的咪唑并[4,5-][1,10]菲咯啉配体(IP-T)。对配合物进行了表征,并研究了它们的电化学、光谱和(光)生物学性质。T 单元的电化学氧化移动了-350 mV,而 = 1 → 4(对于 ,+920 mV;对于 ,+570 mV)。在配合物 (-2530 mV)和 (-2300 mV)中观察到 T 还原。单线态氧量子产率范围为 0.53 至 0.88, 和 同样有效(约 0.88)。-的时间分辨吸收光谱主要由金属到配体电荷转移(MLCT)态主导(τ = 0.40-0.85 μs),但在 -中观察到长寿命的内配体电荷转移(ILCT)态(τ = 25-148 μs)。和 的 ILCT 能量分别计算为 1.6 和 1.4 eV。在宽带可见光(400-700 nm)下对黑素瘤细胞(SK-MEL-28)的光疗功效随 = 0 → 4 而增加: 直至 300 μM 时仍不活跃,-为中度活性(EC ∼ 600 nM,PI = 200), 和 (EC = 57 nM,PI > 1100)和 (EC = 740 pM,PI = 114,000)的光毒性最大。活性随波长的增加而减弱,除了 和 之外,所有配合物在缺氧时都完全被抑制。 在七个生物学重复中,作为更有效的 PS,平均 EC = 1.3 μM,平均 PI = 985。 在五个生物学重复中具有缺氧活性,强调了在化合物评估中需要进行生物学重复。单线态氧敏化可能是这些化合物在常氧条件下产生光毒性的原因,但具有氧化还原活性的激发态可能为具有三个或更多噻吩基的配合物提供额外的光活性途径。ILCT 态的寿命延长了 30-40 倍(对于 和 ,比 MLCT 态长),这表明其在光细胞毒性中起主要作用。

相似文献

1
Ru(II) Phenanthroline-Based Oligothienyl Complexes as Phototherapy Agents.
Inorg Chem. 2023 Dec 25;62(51):21181-21200. doi: 10.1021/acs.inorgchem.3c03216. Epub 2023 Dec 11.
2
Ru(II) Oligothienyl Complexes with Fluorinated Ligands: Photophysical, Electrochemical, and Photobiological Properties.
Inorg Chem. 2024 May 27;63(21):9735-9752. doi: 10.1021/acs.inorgchem.3c04382. Epub 2024 May 10.
5
Os(II) Oligothienyl Complexes as a Hypoxia-Active Photosensitizer Class for Photodynamic Therapy.
Inorg Chem. 2020 Nov 16;59(22):16341-16360. doi: 10.1021/acs.inorgchem.0c02137. Epub 2020 Oct 30.
6
NIR-Absorbing Ru Complexes Containing α-Oligothiophenes for Applications in Photodynamic Therapy.
Chembiochem. 2020 Dec 11;21(24):3594-3607. doi: 10.1002/cbic.202000419. Epub 2020 Sep 25.
7
π-Expansive Heteroleptic Ruthenium(II) Complexes as Reverse Saturable Absorbers and Photosensitizers for Photodynamic Therapy.
Inorg Chem. 2017 Mar 20;56(6):3245-3259. doi: 10.1021/acs.inorgchem.6b02624. Epub 2017 Mar 6.
8
Strained ruthenium metal-organic dyads as photocisplatin agents with dual action.
J Inorg Biochem. 2016 May;158:45-54. doi: 10.1016/j.jinorgbio.2016.01.009. Epub 2016 Jan 9.
9
String-Attached Oligothiophene Substituents Determine the Fate of Excited States in Ruthenium Complexes for Photodynamic Therapy.
J Phys Chem A. 2021 Aug 19;125(32):6985-6994. doi: 10.1021/acs.jpca.1c04900. Epub 2021 Aug 9.

引用本文的文献

1
Green Synthesis of Gold Nanoparticles and Their Cytotoxic Effect in Breast Cancer: An Experimental and Theoretical Study.
ACS Appl Bio Mater. 2025 Aug 18;8(8):7490-7503. doi: 10.1021/acsabm.5c01172. Epub 2025 Jul 31.
5
Leveraging the Photofunctions of Transition Metal Complexes for the Design of Innovative Phototherapeutics.
Small Methods. 2024 Nov;8(11):e2400563. doi: 10.1002/smtd.202400563. Epub 2024 Sep 25.
7
Ru(II) Oligothienyl Complexes with Fluorinated Ligands: Photophysical, Electrochemical, and Photobiological Properties.
Inorg Chem. 2024 May 27;63(21):9735-9752. doi: 10.1021/acs.inorgchem.3c04382. Epub 2024 May 10.
8
Controlling Excited State Localization in Bichromophoric Photosensitizers via the Bridging Group.
Inorg Chem. 2024 Mar 18;63(11):4947-4956. doi: 10.1021/acs.inorgchem.3c04110. Epub 2024 Mar 4.

本文引用的文献

1
Synergic vascular photodynamic activity by methylene blue-curcumin supramolecular assembly.
Spectrochim Acta A Mol Biomol Spectrosc. 2023 Dec 15;303:123281. doi: 10.1016/j.saa.2023.123281. Epub 2023 Aug 19.
2
Bifunctional Cascading Nanozymes Based on Carbon Dots Promotes Photodynamic Therapy by Regulating Hypoxia and Glycolysis.
ACS Nano. 2023 Sep 12;17(17):16715-16730. doi: 10.1021/acsnano.3c03169. Epub 2023 Aug 18.
4
Mitochondria in colorectal cancer stem cells - a target in drug resistance.
Cancer Drug Resist. 2023 May 6;6(2):273-283. doi: 10.20517/cdr.2022.116. eCollection 2023.
5
Cyclic Ruthenium-Peptide Conjugates as Integrin-Targeting Phototherapeutic Prodrugs for the Treatment of Brain Tumors.
J Am Chem Soc. 2023 Jul 12;145(27):14963-14980. doi: 10.1021/jacs.3c04855. Epub 2023 Jun 28.
6
Near-infrared-activated anticancer platinum(IV) complexes directly photooxidize biomolecules in an oxygen-independent manner.
Nat Chem. 2023 Jul;15(7):930-939. doi: 10.1038/s41557-023-01242-w. Epub 2023 Jun 22.
7
Naphthalene Diimide-Functionalized Half-Sandwich Ru(II) Complexes as Mitochondria-Targeted Anticancer and Antimetastatic Agents.
Inorg Chem. 2023 Jun 19;62(24):9649-9660. doi: 10.1021/acs.inorgchem.3c01125. Epub 2023 Jun 2.
8
Exploring Structure-Activity Relationships in Photodynamic Therapy Anticancer Agents Based on Ir(III)-COUPY Conjugates.
J Med Chem. 2023 Jun 22;66(12):7849-7867. doi: 10.1021/acs.jmedchem.3c00189. Epub 2023 Jun 2.
9
Photoactivation of Boronic Acid Prodrugs via a Phenyl Radical Mechanism: Iridium(III) Anticancer Complex as an Example.
J Am Chem Soc. 2023 May 10;145(18):10082-10091. doi: 10.1021/jacs.3c00254. Epub 2023 Apr 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验